Cytokine expression by invariant natural killer T cells is tightly regulated throughout development and settings of type-2 inflammation

Mucosal Immunology

Volumn 9, Issue 3, 2016, Pages 597-609

  O'Brien, T F ^a   Bao, K ^a   Dell'Aringa, M ^a   Ang, W X G ^a   Abraham, S ^a   Reinhardt, R L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 4; TRANSCRIPTION FACTOR GATA 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TRACKING; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; INVARIANT NATURAL KILLER T CELL 1; INVARIANT NATURAL KILLER T CELL 17; INVARIANT NATURAL KILLER T CELL 2; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REPORTER GENE; T LYMPHOCYTE SUBPOPULATION; TYPE 2 INFLAMMATION; ANIMAL; ASTHMA; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PYROGLYPHIDAE; THYMUS;

ANIMALS; ASTHMA; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-4; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; PYROGLYPHIDAE; T-LYMPHOCYTE SUBSETS; THYMUS GLAND;

EID: 84964932891     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2015.78     Document Type: Article

References (57)

1. Pulendran, B. & Artis, D. New paradigms in type 2 immunity. Science 337, 431-435 (2012).
2. Locksley, R.M. Asthma and allergic inflammation. Cell 140, 777-783 (2010).
3. Fallon, P.G. et al. IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity 17, 7-17 (2002).
4. Liang, H.E., Reinhardt, R.L., Bando, J.K., Sullivan, B.M., Ho, I.C. & Locksley, R.M. Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity. Nat. Immunol. 13, 58-66 (2012).
5. Grunig, G. et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282, 2261-2263 (1998).
6. Wills-Karp, M. et al. Interleukin-13: central mediator of allergic asthma. Science 282, 2258-2261 (1998).
7. Bancroft, A.J., McKenzie, A.N. & Grencis, R.K. A critical role for IL-13 in resistance to intestinal nematode infection. J. Immunol. 160, 3453-3461 (1998).
8. Paget, C. & Trottein, F. Role of type 1 natural killer T cells in pulmonary immunity. Mucosal Immunol. 6, 1054-1067 (2013).
9. Middendorp, S. & Nieuwenhuis, E.E. NKT cells in mucosal immunity. Mucosal Immunol. 2, 393-402 (2009).
10. Lisbonne,M. et al. Cutting edge: invariant Valpha 14 NKTcells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 171, 1637-1641 (2003).
11. Akbari, O. et al. Essential role of NKTcells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9, 582-588 (2003).
12. Matsuda, H. et al. Plasticity of invariant NKTcell regulation of allergic airway disease is dependent on IFN-gamma production. J. Immunol. 185, 253-262 (2010).
13. Cui, J. et al. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells. J. Exp. Med. 190, 783-792 (1999).
14. Chandra, S. & Kronenberg, M. Activation and function of iNKT and MAIT cells. Adv. Immunol. 127, 145-201 (2015).
15. Iwamura, C. & Nakayama, T. Role of NKT cells in allergic asthma. Curr. Opin. Immunol. 22, 807-813 (2010).
16. Thomas, S.Y., Chyung, Y.H. & Luster, A.D. Natural killer T cells are not the predominant T cell in asthma and likely modulate, not cause, asthma. J. Allergy Clin. Immunol. 125, 980-984 (2010).
17. Akbari, O. et al. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N. Engl. J. Med. 354, 1117-1129 (2006).
18. Stetson, D.B. et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198, 1069-1076 (2003).
19. Matsuda, J.L. et al. Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo. Proc. Natl. Acad. Sci. USA 100, 8395-8400 (2003).
20. Michel, M.L. et al. Identification of an IL-17-producing NK1.1(neg) iNKTcell population involved in airway neutrophilia. J. Exp. Med. 204, 995-1001 (2007).
21. Coquet, J.M. et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1-NKTcell population. Proc. Natl. Acad. Sci. USA 105, 11287-11292 (2008).
22. Matsuda, J.L., Mallevaey, T., Scott-Browne, J. & Gapin, L. CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system. Curr. Opin. Immunol. 20, 358-368 (2008).
23. Watarai, H. et al. Development and function of invariant natural killer T cells producing T(h)2-and T(h)17-cytokines. PLoS Biol. 10, e1001255 (2012).
24. Lee, Y.J., Holzapfel, K.L., Zhu, J., Jameson, S.C. & Hogquist, K.A. Steadystate production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat. Immunol. 14, 1146-1154 (2013).
25. Carr, T., Krishnamoorthy, V., Yu, S., Xue, H.H., Kee, B.L. & Verykokakis, M. The transcription factor lymphoid enhancer factor 1 controls invariant natural killer T cell expansion and Th2-type effector differentiation. J. Exp. Med. 212, 793-807 (2015).
26. Pellicci, D.G., Hammond, K.J., Uldrich, A.P., Baxter, A.G., Smyth, M.J. & Godfrey, D.I. A natural killer T (NKT) cell developmental pathway involving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage. J. Exp. Med. 195, 835-844 (2002).
27. Benlagha, K., Kyin, T., Beavis, A., Teyton, L. & Bendelac, A. A thymic precursor to the NK T cell lineage. Science 296, 553-555 (2002).
28. Benlagha, K., Wei, D.G., Veiga, J., Teyton, L. & Bendelac, A. Characterization of the early stages of thymic NKT cell development. J. Exp. Med. 202, 485-492 (2005).
29. Dickgreber, N. et al. Immature murine NKT cells pass through a stage of developmentally programmed innate IL-4 secretion. J. Leukoc. Biol. 92, 999-1009 (2012).
30. Price, A.E. et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl. Acad. Sci. USA 107, 11489-11494 (2010).
31. Mohrs, M., Shinkai, K., Mohrs, K. & Locksley, R.M. Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity 15, 303-311 (2001).
32. Mohrs, K., Wakil, A.E., Killeen, N., Locksley, R.M. & Mohrs, M. A two-step process for cytokine production revealed by IL-4 dual-reporter mice. Immunity 23, 419-429 (2005).
33. Jin,C. et al. Particulate allergens potentiate allergic asthma inmice through sustained IgE-mediated mast cell activation. J. Clin. Invest. 121, 941-955 (2011).
34. Ouyang, W. et al. Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 12, 27-37 (2000).
35. Oliver, P.M. et al. Ndfip1 protein promotes the function of itch ubiquitin ligase to prevent Tcell activation and T helper 2 cell-mediated inflammation. Immunity 25, 929-940 (2006).
36. Yamashita, M. et al. Ras-ERK MAPK cascade regulates GATA3 stability and Th2 differentiation through ubiquitin-proteasome pathway. J. Biol. Chem. 280, 29409-29419 (2005).
37. Fang, D. et al. Dysregulation of T lymphocyte function in itchy mice: A role for Itch in TH2 differentiation. Nat. Immunol. 3, 281-287 (2002).
38. Jin, H.S., Park, Y., Elly, C. & Liu, Y.C. Itch expression by Treg cells controls Th2 inflammatory responses. J. Clin. Invest. 123, 4923-4934 (2013).
39. Serafini, N. et al. Gata3 drives development of RORgammat+ group 3 innate lymphoid cells. J. Exp. Med. 211, 199-208 (2014).
40. Gessner, A., Mohrs, K. & Mohrs, M. Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production. J. Immunol. 174, 1063-1072 (2005).
41. Loots, G.G. et al. Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science 288, 136-140 (2000).
42. Kelly, B.L. & Locksley, R.M. Coordinate regulation of the IL-4, IL-13, and IL-5 cytokine cluster in Th2 clones revealed by allelic expression patterns. J. Immunol. 165, 2982-2986 (2000).
43. Dolganov, G. et al. Coexpression of the interleukin-13 and interleukin-4 genes correlates with their physical linkage in the cytokine gene cluster on human chromosome 5q23-31. Blood 87, 3316-3326 (1996).
44. Kishikawa, H., Sun, J., Choi, A., Miaw, S.C. & Ho, I.C. The cell type-specific expression of the murine IL-13 gene is regulated by GATA-3. J. Immunol. 167, 4414-4420 (2001).
45. Zhang, D.H., Yang, L. & Ray, A. Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3. J. Immunol. 161, 3817-3821 (1998).
46. Zhu, J. et al. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat. Immunol. 5, 1157-1165 (2004).
47. Mjosberg, J. et al. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 37, 649-659 (2012).
48. Hoyler, T. et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37, 634-648 (2012).
49. Wang, Z.Y., Kusam, S., Munugalavadla, V., Kapur, R., Brutkiewicz, R.R. & Dent, A.L. Regulation of Th2 cytokine expression in NKT cells: unconventional use of Stat6, GATA-3, and NFAT2. J. Immunol. 176, 880-888 (2006).
50. Zheng,W. & Flavell, R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587-596 (1997).
51. Yamashita, M. et al. Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci. J. Biol. Chem. 279, 26983-26990 (2004).
52. Klein Wolterink, R.G. et al. Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells. Proc.Natl. Acad. Sci.USA110, 10240-10245 (2013).
53. Barlow, J.L. et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J. Allergy Clin. Immunol. 132, 933-941 (2013).
54. Saenz, S.A. et al. IL-25 simultaneously elicits distinct populations of innate lymphoid cells and multipotent progenitor type 2 (MPPtype2) cells. J. Exp. Med. 210, 1823-1837 (2013).
55. Corren, J. et al. Lebrikizumab treatment in adults with asthma. N. Engl. J. Med. 365, 1088-1098 (2011).
56. Voehringer, D., Reese, T.A., Huang, X., Shinkai, K. & Locksley, R.M. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic noneosinophil cells of the innate immune system. J. Exp. Med. 203, 1435-1446 (2006).
57. Frelin, C. et al. GATA-3 regulates the self-renewal of long-term hematopoietic stem cells. Nat. Immunol. 14, 1037-1044 (2013).